Vacaville, CA, United States of America

Hal S Padgett

USPTO Granted Patents = 16 


Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2002-2024

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Hal S. Padgett: Innovator in Anti-Fibrotic Therapies

Introduction

Hal S. Padgett, a prominent inventor based in Vacaville, CA, has made significant contributions to the field of biotechnology. With a prolific portfolio of 16 patents, Padgett's work primarily focuses on developing innovative solutions for treating fibrosis, a condition characterized by excessive connective tissue buildup.

Latest Patents

Among his recent patents, Padgett has worked on "Endostatin fragments and variants for use in treating fibrosis." This patent describes materials and methods that utilize polypeptides containing fragments and variants of endostatin to effectively target and treat fibrosis. Additionally, his patent titled "Materials and methods for producing endostatin fusion polypeptides in plant cells" outlines the techniques for generating fusion polypeptides in plant cells, which possess anti-fibrotic activity. This fusion polypeptide includes an IgG Fc domain and a portion of human endostatin capable of forming high molecular weight multimers, showcasing innovative methods for production that could enhance therapeutic efficacy.

Career Highlights

Hal S. Padgett has worked with esteemed companies in the biotech industry, including Novici Biotech LLC and Large Scale Biology Corporation. Through his work at these organizations, he has been able to harness cutting-edge technology to advance his research and develop impactful innovations.

Collaborations

Padgett's journey has also included collaborations with notable coworkers such as John A. Lindbo and Wayne P. Fitzmaurice. These partnerships have played a vital role in the shared exploration and development of new therapeutic approaches to address health challenges related to fibrosis.

Conclusion

Hal S. Padgett continues to be a leading figure in biotechnology through his inventive work and collaborations. His contributions, particularly in the realm of anti-fibrotic therapies, have the potential to transform treatment methodologies and improve patient outcomes in the fight against fibrosis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…